PCSK9 Forum
Click here to forward this email to a colleague
Facebook Twitter RSS YouTube linkedin
Home  |  About  |  PCSK9  |  News  |  Commentary  |  Trials  |  Videos  |  Resources  |  Contact
News from the 15th Closed Scientific Expert Meeting of the Editorial Board of PCSK9 Education and Research Forum

Virtual Meeting: 22 November 2021
Critical questions in PCSK9 research

Where next for cost-effectiveness analysis of combination LDL lowering therapies?

Dr Dhruv Kazi, Beth Israel Deaconess Medical Center, and Harvard Medical School, Boston, USA considers future directions for cost-effectiveness analysis of combination lipid lowering therapies.
Dhruv Kazi's presentation
Watch the presentation »

Is a 'once-and-done' approach to LDL lowering feasible?

 Prof Kiran Musunuru, University of Pennsylvania, USA overviews the latest developments with CRISPR base editing of PCSK9 and considerations for future trials.

Kiran Musunuru's presentation
Watch the presentation »
 
Question of the month

What does the future hold for CRISPR base editing of PCSK9?


    Watch the video »    
CRISPR video
TG Forum
Like us
For the latest updates, PCSK9 news and analysis.
Follow us
Hot topics, news and conference reports.
YouTube Channel
For videos, interviews and webcasts from leading experts.
Educational Partners
and Supporters 		Amgen Novartis Sanofi
Copyright PCSK9 Forum 2021. Please click here to unsubscribe from future mailings . View on the web